<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="22">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01801813</url>
  </required_header>
  <id_info>
    <org_study_id>RC12_0416</org_study_id>
    <nct_id>NCT01801813</nct_id>
  </id_info>
  <brief_title>Risk Factors of Complications Regarding Patients Undergoing Brain Tumour Neuro-surgery (Cranioscore).</brief_title>
  <acronym>Cranioscore</acronym>
  <official_title>Observational Study of Risk Factors of Neuro-critical Care Complications Regarding Patients Undergoing Brain Tumour Neuro-surgery : a Prospective Validation of the Cranioscore.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing a brain tumour neurosurgery with craniotomy may present rare but
      lifethreatening post-operative complications. There are currently no strong recommendations
      to help the clinician in an attempt to properly hospitalise these patients after their
      intervention (Neuro-ICU, ICU,surgical ward).

      Determining risk factors of post-operative complications could optimise resources. Therefore
      hospitalisation in Neuro-ICU would be mandatory in only a little number of patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective analysis of a prospective database to create a Risk Score. Post-operative
      neurosurgery complications recording (Hyponatremia &lt; 135mmol/l,Insulin administration,
      Nausea-Vomiting, Glasgow Coma Score, Inhalation, Post-operative intra-cranial bleeding
      requiring neurosurgery, Intra-cranial hypertension, Use of osmotherapy, Status epilepticus,
      Brain death, Death).

      Collection of datas as Duration of mechanical ventilation, Length of ICU stay, Length of
      hospital stay.

      Validation of this score on an independent prospective cohort.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>Post-operative complications requiring Neuro-ICU stay â‰¥ 24 hours after surgery for neurosurgical reason.</measure>
    <time_frame>During ICU stay, average of 24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Describing post-operative complications in patients undergoing neuro-surgery for brain tumor.</measure>
    <time_frame>During ICU stay, average of 24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hyponatremia &lt; 135mmol/l,Insulin administration, Nausea-Vomiting, Glasgow Coma Score, Inhalation, Post-operative intra-cranial bleeding requiring neurosurgery Intra-cranial hypertension, Use of osmotherapy, Status epilepticus, Brain death Death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>Duration of mechinal ventilation, average of 12 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Duration of ICU stay, average of 24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Duration of hospital stay, expected average 5 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Neuro-surgery,</condition>
  <condition>Brain Tumor,</condition>
  <condition>Post-operative Complications,</condition>
  <condition>Neuro-ICU Stay</condition>
  <arm_group>
    <arm_group_label>Neurosurgery for brain tumor patients</arm_group_label>
    <description>Collecting pre-operative and per-operative data, neuro-radiological data and post-operative complications</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Collecting pre-operative, per-operative data, neuro-radiological data and post-operative neuro-surgery complications</intervention_name>
    <arm_group_label>Neurosurgery for brain tumor patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing neuro-surgery for a brain tumor
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing neuro-surgery for a brain tumor

        Exclusion Criteria:

          -  Neuro-surgical emergency
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karim ASEHNOUNE, PhD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raphael CINOTTI, MD</last_name>
    <phone>02 40 06 53 41</phone>
    <phone_ext>33</phone_ext>
    <email>raphael.cinotti@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphael CINOTTI, MD</last_name>
      <email>raphael.cinotti@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Raphael CINOTTI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Ziai WC, Varelas PN, Zeger SL, Mirski MA, Ulatowski JA. Neurologic intensive care resource use after brain tumor surgery: an analysis of indications and alternative strategies. Crit Care Med. 2003 Dec;31(12):2782-7.</citation>
    <PMID>14668615</PMID>
  </reference>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 27, 2013</lastchanged_date>
  <firstreceived_date>February 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuro-surgery</keyword>
  <keyword>Post-operative complications</keyword>
  <keyword>Neuro-ICU resources</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
